In the past five years, UT Health San Antonio has conducted more than 600 clinical research projects with one goal in mind — making lives better for people in San Antonio, Texas and beyond through innovative solutions to today’s most challenging health problems.
Share This Story
Nina Murray admits she was “one of those people” who rarely went to the dentist. But going, when she did, might have saved her life. Last September, she detected what she first thought was an ulcer inside her right cheek, but it quickly turned into a hard lump and started hurting. “Something’s not right,” she […]
Share This Story
Discovery of chemical endocytosis could redefine precision medicine A team of scientists, notably Zhengyu Wang, PhD, assistant professor in the department of pharmacology and the Barshop Institute, led by Hong-yu Li, PhD, professor of medicinal chemistry and chemical biology with the department of pharmacology and the Barshop Institute at The University of Texas Health Science […]
Share This Story
On April 5, more than a thousand participants gathered for the annual Give Cancer the Boot Survivorship 5K and 1-Mile Walk, dedicated to honoring survivors and supporting those still in treatment.
Share This Story
BRCA1 and BRCA2 are genes that help protect the body by fixing damaged DNA and keeping cells healthy. When these genes have changes, or mutations, they don’t work the way they should. This can raise the risk of certain cancers, like breast, ovarian, prostate and pancreatic cancer. These inherited mutations affect about 1 in every 200 to 300 people — over a million in the U.S. alone.
Share This Story
Maria E. Falzone, PhD, assistant professor in the Department of Biochemistry and Structural Biology in the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), has received a $150,000 UT Science and Technology Acquisition and Retention (STARs) award from the […]
Share This Story
Alicia Logue, MD, associate professor, Department of Surgery, was interviewed for this episode of The Source. Listen Now
Share This Story
Despite advances in cancer treatment in recent years, five-year survival rates for acute myeloid leukemia (AML) remain low at just 30% on average, according to the National Cancer Institute. Factors in the development of AML are diverse with many different drivers. A longtime goal for scientists in this field is finding a single drug that […]
Share This Story
Will partner with the school to speed oral cancer drug to market A UT Health San Antonio School of Dentistry researcher and her pioneering biotechnology company partnered with the school to earn a prestigious $400,000 Small Business Technology Transfer (STTR) grant from the National Institutes of Health to speed development of a breakthrough oral cancer drug. Cara […]
Share This Story
Research findings, strategies target the leading cause of Latino death With cancer still rising in the U.S. Latino population, leaders at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and national cancer experts have published an online book with innovative recommendations to reduce Latino cancer. The book, “Advancing the […]
Share This Story